Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome.
Costa
Monica Barros
MB
Andrade Ezequiel
Danielle Guedes
DG
Morais Lovis
Julio Cesar
JC
Oliveira
Manoel Marques
MM
Baumgratz de Paula
Rogerio
R
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone